EVAXION BIOTECH A/S — Credit Rating and Financial Key Figures

CVR number: 31762863
Dr Neergaards Vej 5 F, 2970 Hørsholm
nim@novvac.com

Income statement (kDKK)

20182019
Fiscal period length1212
Net sales
Gross profit
Costs of management-1.90
Other operating expenses-3.73-11.20
EBIT-5.63-11.20
Other financial income0.08
Other financial expenses-0.72
Pre-tax profit-6.27-11.20
Income taxes0.73
Net earnings-5.54-11.20

Assets (kDKK)

20182019
Intangible assets total
Other tangible assets0.11
Tangible assets total0.11
Investments total
Non-current prepayments and accrued income0.02
Long term receivables total0.02
Inventories total
Current trade debtors0.24
Current other receivables-9.56
Current deferred tax assets0.71
Short term receivables total0.95-9.56
Cash and bank deposits7.439.56
Cash and cash equivalents7.439.56
Balance sheet total (assets)8.51

Equity and liabilities (kDKK)

20182019
Share capital0.06
Other reserves5.99
Retained earnings-1.4411.20
Profit of the financial year-5.54-11.20
Shareholders equity total-0.93
Non-current leasing loans0.02
Non-current liabilities total0.02
Current leasing loans0.07
Current trade creditors0.14
Other non-interest bearing current liabilities9.21
Current liabilities total9.42
Balance sheet total (liabilities)8.51
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.